Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature 441, 161 (11 May 2006) | doi:10.1038/441161a; Published online 10 May 2006
Open Innovation Challenges
-
Novel Approaches to Protecting Maize from Insect Damage
The Seeker is looking for novel approaches to protecting maize from insect damage. This Challenge re...
-
Methods of Modeling Adaptation in Populations
The analysis of adaptation with a population is a frequently encountered computational modeling scen...
- More Challenges
- Powered by:
nature jobs
Scientist (Bioinformatics)
- Polyclone Bioservices Pvt. Ltd
- Bangalore India
Assoc. Scientific Manager / Scientific Manager - Biopharmaceutics
- Syngene International
- Bangalore, Karnataka 560099 India
Vaccines: Engineering immune evasion
John R. Mascola1
Abstract
One obstacle to realizing the promise of viral vectors for vaccine delivery is pre-existing immunity to such vectors. An adroit application of structure-based design points to a way around that problem.
There are still no vaccines against such devastating and widespread diseases as malaria, tuberculosis and AIDS. Because the traditional approach of live-attenuated vaccination is not feasible for most diseases, scientists have turned to molecularly engineered viruses that contain pathogen-specific gene inserts.
- John R. Mascola is at the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 40 Convent Drive, Bethesda, Maryland 20892-3005, USA.
Email: jmascola@nih.gov
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunityNature Letters to Editor (11 May 2006)
Optimization of vaccine responses with an E1, E2b and E3-deleted Ad5 vector circumvents pre-existing anti-vector immunityCancer Gene Therapy Original Article
Fully Detargeted Polyethylene Glycol-coated Adenovirus Vectors Are Potent Genetic Vaccines and Escape from Pre-existing Anti-adenovirus AntibodiesMolecular Therapy Original Article
Prime-boost vaccination with plasmid DNA and a chimeric adenovirus type 5 vector with type 35 fiber induces protective immunity against HIVGene Therapy Research Article
See all 7 matches for Research